Hutch News

Hutch News

Stories tagged 'Vaccine and Infectious Disease'

Computational biologist Dr. Raphael Gottardo receives 2018 Mortimer Spiegelman Award

American Public Health Association recognizes Fred Hutch researcher for his contributions to health statistics biology

July 13, 2018 | By Tom Kim / Fred Hutch News Service

The American Public Health Association has named Dr. Raphael Gottardo, a computational biologist at Fred Hutchinson Cancer Research Center, the winner of its 2018 Mortimer Spiegelman Award.

View story >


UCI-Fred Hutch collaboration turns 10

In Uganda, innovation and persistence allow a 'sustainable cancer program' to take root

June 12, 2018 | By Mary Engel / Fred Hutch News Service

In Uganda, innovation and persistence allow a "sustainable cancer program" to take root.

View story >


The pride of Fred Hutch

HIV Vaccine Trials Network veteran Steven Wakefield named a grand marshal in Seattle Pride Parade

June 7, 2018 | By Mary Engel / Fred Hutch News Service

During Pride Month, a parade of honors is in store for HIV Vaccine Trials Network veteran Steven Wakefield, external relations director for the Fred Hutch–based global group.

View story >


Dr. Joshua Hill receives Amy Strelzer Manasevit grant award

Award will help fund ‘paradigm shift’ in diagnosing post-transplant infections

June 6, 2018 | By Mary Engel / Fred Hutch News Service

Dr. Joshua Hill, a physician-researcher at Fred Hutch who studies post-transplant complications, has received one of the most coveted honors in the transplantation field.

View story >


Physician assistant Debra Mattson to retire May 24

She has been the historian — and the heart —of the Infectious Disease Consult Service

May 21, 2018 | By Mary Engel / Fred Hutch News Service

After 30 years at Fred Hutch, the historian — and heart — of the Infectious Disease Consult Service leaves us with life advice that is as simple as it is profound: Just be kind.

View story >


First human antibody found to block Epstein-Barr virus

Early research could open new path for vaccine against EBV-related cancers, mononucleosis

April 17, 2018 | By Mary Engel / Fred Hutch News Service

The finding opens a new path to developing a vaccine against EBV, a virus best known for causing mono but which is associated with about 200,000 cancer cases a year.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.